TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AMRN

Amarin Corporation PLC

Healthcare · Drug Manufacturers - General

12.30$ -3.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Amarin Corporation PLC (AMRN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 624 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AMRN
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
194 167 175 170 167 162 216 204 210 386 372 390 867 882 926 915 960 966 990 1,045 1,036 1,068 974 973 908 886 860 860 839 832 790 800 751 685 656 670 660 671 646 624
161 146 155 150 147 153 208 196 202 378 355 372 848 855 817 828 889 879 931 996 963 879 773 719 687 689 684 706 718 725 688 702 650 595 573 607 628 650 626 603
118 98 96 85 79 74 129 102 82 249 211 222 673 645 329 214 207 187 291 327 223 219 219 228 240 218 191 233 271 199 214 216 157 121 120 148 123 135 131 144
118 98 96 85 79 74 129 102 82 249 211 222 673 645 542 550 562 501 515 509 479 454 363 313 304 309 304 313 321 321 309 307 306 294 282 299 287 303 308 315
18 20 29 37 35 45 39 50 73 67 79 95 104 116 158 125 147 155 151 182 149 164 110 144 123 131 133 123 122 134 116 124 113 122 107 119 127 127 108 93
20 21 24 25 29 30 35 40 44 58 58 46 55 77 92 125 149 189 231 272 309 235 268 226 228 229 226 227 254 259 255 239 224 166 159 171 185 196 184 164
0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 9.0 9.6 11 11 11 11 10 10 9.8 9.6 9.3 9.1 10.0 9.7 9.5 9.9 9.4 – – – – – – – – – – – – –
– – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – 13 – –
8.9 8.8 8.6 8.4 8.3 8.1 8.0 7.8 7.6 7.5 7.3 7.2 7.0 15 15 15 14 14 25 25 24 24 23 22 22 22 21 20 20 19 19 18 17 16 16 15 14 13 13 12
179 176 204 209 213 227 232 251 263 233 231 241 271 274 340 312 353 339 356 400 393 401 333 393 320 291 275 291 286 280 244 248 219 199 182 205 201 211 196 181
75 76 78 86 90 109 119 138 152 157 162 185 230 242 310 283 326 307 326 370 365 371 301 362 287 259 244 271 267 259 224 231 202 180 162 186 182 194 180 164
29 31 17 19 20 23 25 28 30 34 39 45 51 50 37 22 9.5 170 1.6 1.6 1.7 208 0.9 -2.2 1.1 10 9.9 – – – 2.3 – – – – – – – – –
6.9 6.1 15 16 16 25 32 34 26 38 27 34 42 50 98 87 121 106 94 141 72 115 91 116 93 65 59 54 53 53 68 54 41 40 46 45 37 45 48 19
89 85 111 108 104 100 95 89 83 46 35 23 8.9 – – – – – – – – – – – – – – – – – – – – – – – – – – –
15 -9.1 -29 -39 -46 -65 -17 -47 -53 152 141 149 596 608 586 603 607 628 635 645 642 667 641 580 588 595 585 569 553 552 546 552 531 486 474 465 459 459 449 444
-1,177 -1,204 -1,225 -1,239 -1,249 -1,272 -1,296 -1,330 -1,355 -1,389 -1,413 -1,415 -1,418 -1,411 -1,432 -1,427 -1,434 -1,429 -1,431 -1,423 -1,436 -1,421 -1,453 -1,523 -1,528 -1,527 -1,544 -1,561 -1,581 -1,586 -1,596 -1,595 -1,620 -1,669 -1,684 -1,698 -1,706 -1,707 -1,718 -1,726
10 13 14 14 14 14 14 15 15 16 16 17 18 17 18 20 19 20 20 20 20 20 20 20 20 20 20 20 20 20 410 21 21 21 21 21 21 21 21 21

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?